Leadless pacemaker for heart failure resynchronization
Part of Heart & circulation clinical trials.
This trial tests a completely leadless pacemaker (WiSE® CRT) for heart failure patients who need cardiac resynchronization therapy (CRT). It aims to avoid the long-term risks of traditional wires (leads) in the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with a low ejection fraction (≤35%) and a specific type of electrical delay in your heart (wide QRS).
- You are either getting a new CRT device or upgrading from an existing pacemaker to a CRT device.
- You are 22 years old or older.
- You are not pregnant, nursing, or planning pregnancy during the study.
- You have a life expectancy of at least 12 months.
- You can attend follow-up visits and follow study requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of pacemaker placement to improve heart function in people with heart failure. One method paces the heart's natural conduction system, while the other paces the lower chambers of the heart. The goal is to find which approach works better for heart resynchronization therapy.
This study tests a new heart scan method to help doctors place pacemakers more accurately for people with heart failure. It aims to improve the effectiveness of the pacemaker treatment and may lead to better outcomes for patients.
This trial tests whether using detailed heart scans (PET and CT) to guide the placement of a special pacing wire can improve outcomes for people with heart failure who have a specific ECG pattern. If you qualify, you may receive more personalized placement of the pacing lead.
This study tests a new way to place a heart device lead to help the heart beat in sync for people with heart failure and a specific abnormal heart rhythm. The goal is to see if this method improves outcomes compared with standard treatment.
This trial tests whether a different pacing approach called left bundle branch pacing can improve outcomes and heart structure changes in people who did not improve with standard biventricular CRT. It may help some patients with ongoing heart failure symptoms and weak heart pumping.
This trial evaluates a noninvasive way to assess who should get Cardiac Resynchronization Therapy (CRT), and to check results after implantation. If you fit the heart rhythm and heart pump criteria, the approach may help confirm whether CRT is appropriate for you.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.